EFSA has proposed the following MRLs recommendations:

 

Substance Commodity Existing EU MRL (ppm) Proposed MRL (ppm) Comment
 Spirotetramat  hazelnuts, macadamia, pecans, pine nuts, pistachios, walnuts 0.5 0.5 Recommended
 apricots, plums 3 3 Recommended
 table grapes 2 2 Recommended
 cranberries 0.7 0.5 Recommended
 Cycloxydim  apricots 0.2 0.09* Recommended
 plums   0.09 0.09* Recommended
 table grapes 0.5 0.4 Recommended
 peanuts 0.2 0.2 Further consideration needed
 Acequinocyl  hazelnuts 0.01* 0.01* Further consideration needed
 plums 0.02 0.03 Recommended
 table grapes 0.3 0.8 Further consideration needed
 cranberries 0.01* 0.01* Recommended
 Fluxapyroxad  almonds, Brazil nuts, cashew nuts,  hazelnuts, macadamia, pecans, pine nuts, pistachios, walnuts 0.04 0.04 Recommended
 plums 1.5 1.5 Recommended
 table grapes 3 3 Recommended
 peanuts 0.01* 0.01* Further consideration needed
 apricots 1 0.15 Further consideration needed
 Abamectin  almonds, hazelnuts, walnuts 0.02 0.01* or 0.006* (a)

* Indicates that the MRL is set at the limit of analytical quantification.
(a) The data gap identified in the MRL review related to the analytical method validation has been addressed. However, the data gaps on residue trials have not been addressed. The lowering of the MRL of 0.02 mg/kg to the LOQ of 0.01 mg/kg should be considered. Since new validation data demonstrated that a lower LOQ is achievable, a risk management discussion is recommended whether it is appropriate to set the MRL at lower LOQ of 0.006 mg/kg.

 
EFSA Reasoned Opinion on the Review of the existing maximum residue levels for spirotetramat according to Article 12 of Regulation (EC) No 396/2005. EFSA Journal 2020;18(1):5960

EFSA Reasoned Opinion on the Review of the existing maximum residue levels for cycloxydim according to Article 12 of Regulation (EC) No 396/2005. EFSA Journal 2020;18(1):5962
 
EFSA Reasoned Opinion on the Review of the existing maximum residue levels for acequinocyl according to Article 12 of Regulation (EC) No 396/2005. EFSA Journal 2020;18(1):5983

EFSA Reasoned Opinion on the Review of the existing maximum residue levels for fluxapyroxad according to Article 12 of Regulation (EC) No 396/2005. EFSA Journal 2020;18(1):5984

EFSA Reasoned Opinion on the Evaluation of confirmatory data following the Article 12 MRL review and modification of the existing maximum residue levels for abamectin in various commodities. EFSA Journal 2020;18(1):5989

Join us

Sign up to become a member of the INC and discover the benefits of INC membership. Or subscribe and have access to our magazine, industry newsletters and industry directory.

Privacy Preference Center